The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...

Signos’s glucose-tracking system uses AI and real-time data to guide healthier habits—no prescription required.

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...

Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s ...

Palo Alto, California-based Signos integrated the Dexcom Stelo OTC continuous glucose monitor (CGM) with an AI-powered ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...